Acquisition Press Release Examples [+ Templates]

Acquisition Press Releases

An acquisition press release is a critical tool for informing the media about a company’s acquisition of another entity, marking a significant moment for business growth and market expansion. It’s essential to ensure that the press release is newsworthy, providing meaningful information suitable for media outlets.

In this article we’ll provide:

Acquisition Press Release Examples

Writing is always easier when you have an example to work from. So we decided to give you not just one, but 14 different examples of real press releases that you can use for ideas and models for the one you’re writing.

Press release distribution service

Example #1: Tech Company Acquisition

Amplix Expands Portfolio with Acquisition of Florida-Based Trusted Advisor nQuery Communications

NORWOOD, Mass., Oct. 30, 2023 /PRNewswire/ — Amplix, a portfolio company of Gemspring Capital and a leading provider of technology advisory services and software, today announced the acquisition of substantially all of the assets of M.J.M. ENTERPRISES, LLC., dba nQuery Communications (“nQuery”). Terms of the transaction were not disclosed.

Founded in 2003 and based in Miami, Florida, nQuery serves as a trusted advisor to approximately 250 enterprise and SMB customers across various end markets. nQuery provides best-in-class, unbiased advisory services across a range of cloud-oriented offerings – including unified communications, business internet, contact center, and IT and cybersecurity – to help customers evaluate and implement the most efficient and reliable services across their businesses. Over the past 20 years, nQuery has developed a diversified base of customers in the rapidly expanding Florida market, distinguished by its reputation for providing exceptional, hands-on service.

Joe DeStefano, the CEO of Amplix, commented, “nQuery’s integration into the Amplix platform is a significant strategic milestone for our business. nQuery will bolster our existing presence in the flourishing Florida region, ultimately benefiting both our existing and new clients. We eagerly anticipate collaborating with the talented team at nQuery to further enhance the technology investment returns for our combined base of valued customers.”

Emilio Diaz, the Founder of nQuery, shared, “Our partnership with Amplix marks an exciting chapter in nQuery’s journey of growth and innovation, and aligns seamlessly with our commitment to delivering exceptional value to our customers. We are thrilled to complement our service offerings with the additional resources, capabilities and scale of the Amplix platform.”

About nQuery

nQuery is a provider of technology advisory services and software to customers across multiple industries, serving as a trusted resource to its clients by enabling IT professionals to make more informed decisions to optimize technology spending. nQuery’s advisory services span connectivity, cloud telephony, and managed services. nQuery is headquartered in Miami, Florida. For more information, visit

About Amplix

Amplix is a provider of strategic technology advisory, consulting, implementation, and managed services to more than 3,500 customers nationwide, enabling data-driven enhancements to technology decision-making and optimization. Amplix advisory services encompass customer experience, data connectivity, security, and managed services, cloud telephony, mobility, cloud optimization, business continuity, and data center solutions. Amplix is headquartered in Norwood, Massachusetts with over 150 employees in over 20 states and Canada. For more information, visit

About Gemspring Capital

Gemspring Capital, a Westport, Connecticut-based private equity firm with $3.5 billion of capital under management, provides flexible capital solutions to middle market companies. Gemspring partners with talented management teams and takes a partnership approach to helping drive revenue growth, value creation and sustainable competitive advantages. Target companies have up to $500 million in revenue and are in the aerospace & defense, business services, consumer services, financial and insurance services, healthcare services, industrial services, software and tech-enabled services, or specialty manufacturing sectors. For more information, visit

CONTACT: Zubin Malkani ([email protected]) or Dan Gill ([email protected])

SOURCE Gemspring Capital

Example #2: Biopharmaceutical acquisition (including forward-looking statements)

Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology

INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., June 20, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and DICE Therapeutics, Inc. (NASDAQ: DICE) today announced a definitive agreement for Lilly to acquire DICE.

DICE is a biopharmaceutical company that leverages its proprietary DELSCAPE technology platform to develop novel oral therapeutic candidates, including oral IL-17 inhibitors currently in clinical development, to treat chronic diseases in immunology.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” said Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer. “We welcome DICE colleagues to Lilly and, together, we can tackle the challenges ahead in finding new treatments for patients with significant unmet medical needs.”

Kevin Judice, Ph.D., CEO of DICE Therapeutics, added: “We’re eager to see our pipeline, including our oral IL-17 inhibitors, DC-806 and DC-853, benefit from Lilly’s resources and global reach and I’m excited by the prospect of watching these two talented teams in a united quest for scientific innovation. Our novel approach to discovering and advancing oral, small molecules against validated protein-protein interaction targets has even greater potential with Lilly’s industry-leading clinical development capabilities to get these medicines to patients suffering from autoimmune diseases.”

Terms of the Agreement

Lilly will commence a tender offer to acquire all outstanding shares of DICE for a purchase price of $48 per share in cash (an aggregate of approximately $2.4 billion) payable at closing. The transaction has been approved by the boards of directors of both companies.

The transaction is not subject to any financing condition and is expected to close in the third quarter of 2023, subject to customary closing conditions, including receipt of required antitrust clearance and the tender of a majority of the outstanding shares of DICE’s common stock. Following the successful closing of the tender offer, Lilly will acquire any shares of DICE that are not tendered in the tender offer through a second-step merger at the same consideration as paid in the tender offer.

The purchase price payable at closing represents a premium of approximately 40% to the 30-day volume-weighted average trading price of DICE’s common stock ended on June 16, 2023, the last trading day before the announcement of the transaction. DICE’s Board of Directors unanimously recommends that DICE’s stockholders tender their shares in the tender offer.

Lilly will determine the accounting treatment of this transaction as a business combination or an asset acquisition, including any related acquired in-process research and development charges, according to Generally Accepted Accounting Principles (GAAP) upon closing. This transaction will thereafter be reflected in Lilly’s financial results and financial guidance.

For Lilly, Kirkland & Ellis LLP is acting as legal counsel. For DICE, Centerview Partners LLC is acting as exclusive financial advisor and Fenwick & West LLP as legal counsel.

About DICE Therapeutics, Inc.

DICE Therapeutics, Inc. is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. DICE is initially focused on developing oral therapeutics against well-validated targets in immunology, with the goal of achieving comparable potency to their systemic biologic counterparts, which have demonstrated the greatest therapeutic benefit to date in these disease areas. The Company’s DELSCAPE platform is designed to discover selective oral small molecules with the potential to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. DICE’s lead therapeutic candidates are oral antagonists of the pro-inflammatory signaling molecule, IL-17, which is a validated drug target implicated in a variety of immunology indications. DICE is also developing oral therapeutic candidates targeting the integrin α4ß7 for the treatment of inflammatory bowel disease.

About Lilly

Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit and or follow us on Facebook, Instagram, Twitter and LinkedIn. C-LLY

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements regarding Lilly’s proposed acquisition of DICE, including regarding prospective benefits of the proposed acquisition and the DELSCAPE platform, regarding the anticipated occurrence, manner and timing of the proposed tender offer and the closing of the proposed acquisition, regarding the Company’s product candidates and ongoing clinical and preclinical development, and regarding the accounting treatment of the potential acquisition under GAAP and its potential impact on Lilly’s financial results and financial guidance. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements reflect current beliefs and expectations; however, these statements involve inherent risks and uncertainties, including with respect to consummating the proposed acquisition and any competing offers or acquisition proposals for DICE, drug research, development and commercialization, Lilly’s evaluation of the accounting treatment of the potential acquisition and its potential impact on its financial results and financial guidance, uncertainties as to how many of DICE’s stockholders will tender their stock in the tender offer, the effects of the proposed acquisition (or the announcement thereof) on DICE’s stock price, relationships with key third parties or governmental entities, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting management’s attention from DICE’s ongoing business operations, changes in DICE’s business during the period between announcement and closing of the proposed acquisition, and any legal proceedings that may be instituted related to the proposed acquisition. Actual results could differ materially due to various factors, risks and uncertainties. Among other things, there can be no guarantee that the proposed acquisition will be completed in the anticipated timeframe or at all, that the conditions required to complete the proposed acquisition will be met, that any event, change or other circumstance that could give rise to the termination of the definitive agreement for the proposed acquisition will not occur, that Lilly will realize the expected benefits of the proposed acquisition, that product candidates will be approved on anticipated timelines or at all, that any products, if approved, will be commercially successful, that Lilly’s financial results will be consistent with its expected 2023 guidance or that Lilly can reliably predict the impact of the proposed acquisition on its financial results or financial guidance. For further discussion of these and other risks and uncertainties, see Lilly’s and DICE’s most recent Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission (the “SEC”). Except as required by law, neither Lilly nor DICE undertakes any duty to update forward-looking statements to reflect events after the date of this press release.

Additional Information about the Acquisition and Where to Find It

The tender offer for the outstanding shares of DICE described in this communication has not yet commenced. This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any securities, nor is it a substitute for the tender offer materials that Lilly and its acquisition subsidiary will file with the SEC upon commencement of the tender offer. A solicitation and offer to buy outstanding shares of DICE will only be made pursuant to the tender offer materials that Lilly and its acquisition subsidiary intend to file with the SEC. At the time the tender offer is commenced, Lilly and its acquisition subsidiary will file tender offer materials on Schedule TO, and DICE will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC with respect to the tender offer. THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE PARTIES THERETO. INVESTORS AND STOCKHOLDERS OF DICE ARE URGED TO READ THESE DOCUMENTS CAREFULLY WHEN THEY BECOME AVAILABLE (AND EACH AS IT MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME) BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT INVESTORS AND STOCKHOLDERS OF DICE SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR SHARES OF COMMON STOCK IN THE TENDER OFFER. The tender offer materials (including the Offer to Purchase and the related Letter of Transmittal), as well as the Solicitation/Recommendation Statement, will be made available to all stockholders of DICE at no expense to them at Lilly’s website at and (once they become available) will be mailed to the stockholders of DICE free of charge. The information contained in, or that can be accessed through, Lilly’s website is not a part of, or incorporated by reference herein. The tender offer materials (including the Offer to Purchase and the related Letter of Transmittal), as well as the Solicitation/Recommendation Statement, will also be made available for free on the SEC’s website at In addition to the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, Lilly and DICE file annual, quarterly, and current reports, proxy statements and other information with the SEC. You may read any reports, statements or other information filed by Lilly and DICE with the SEC for free on the SEC’s website at

Refer to:     

Jordan Bishop; [email protected]; 317-473-5712 (Media)

Joe Fletcher; [email protected]; 317-296-2884 (Investors)

Dan Budwick; [email protected] (DICE Media and Investors)

Example #3: Acqui-hire acquisition to get new employees

Neo4j Acqui-hires Cloud Managed Services Team in Major Expansion of Graph Enterprise Deployment Offering

Move is driven by customer demand as graph scales across hybrid and multi-cloud environments

SAN MATEO, Calif., March 14, 2023 /PRNewswire/ — Neo4j®, the graph database and analytics leader, announced the strategic acqui-hire of 11 full-time specialists from Distributed Technology Associates (DTA) in a major expansion of its global cloud managed services (CMS) capability. The result gives enterprise customers greater choice in Neo4j deployment models and faster execution, coming at a time when graph is scaling rapidly across hybrid and multi-cloud environments.

DTA founder and CEO Sanjay Tikku will lead the expanded offering at Neo4j, overseeing teams across the U.S. and India.  Neo4j and DTA started their partnership in 2017, providing 24×7 service and support to enterprise customers across North America, EMEA, Asia-Pacific, and South America.

“Customers are leveraging graphs to help solve their most pressing business challenges, from generative AI to fraud detection, customer 360, knowledge graphs, supply chain, and more,” said Alyson Welch, Chief Revenue Officer, Neo4j. “This is due to graph’s unique ability to find hidden relationships and patterns across billions of data connections. As graph scales across multiple data environments, it simply made sense to integrate Sanjay and his brilliant team of Neo4j CMS experts within Neo4j itself.”

The acqui-hire follows a series of acknowledgements for the company. In December 2022, Neo4j was recognized for the first time in the Gartner®️ Magic Quadrant™️ for Cloud Database Management Systems, which was also the first time that any native graph vendor had been recognized. Other milestones included the general availability last Neo4j 5 last November, the company’s next-generation cloud-ready graph database, rapid adoption of its Graph Data Science analytics and machine learning platform, continued double-digit growth in 2022 after crossing $100 million in annual recurring revenue (ARR) in 2021, and major innovations following last year’s raise of the largest funding round in database history.

“Graph solves a pain point for enterprises who otherwise find it increasingly complex, painstaking, slow, and expensive to manage and understand the relationships across billions of data connections,” said Sanjay Tikku. “This is why Neo4j’s technology is used today by more than 75 percent of the Fortune 100 – and it’s just the beginning. I’m thrilled to provide customers with more choices and control over Neo4j deployment models, enabling them to achieve scale, performance, efficiency, and compliance.”

Click here for more information on Neo4j’s global cloud managed services.

Gartner, Magic Quadrant for Cloud Database Management Systems, By Henry Cook, Merv Adrian, Rick Greenwald, Xingyu Gu, 13 December 2022.

GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.

*Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Neo4j

Neo4j, the Graph Database & Analytics leader, helps organizations find hidden relationships and patterns across billions of data connections deeply, easily and quickly. Customers leverage the structure of their connected data to reveal new ways of solving their most pressing business problems, from fraud detection, customer 360, knowledge graphs, supply chain, personalization, IoT, network management, and more – even as their data grows. Neo4j’s full graph stack delivers powerful native graph storage, data science, advanced analytics, and visualization, with enterprise-grade security controls, scalable architecture and ACID compliance. Neo4j’s community of data leaders comprises a vibrant, open-source community of more than 250,000 developers, data scientists, and architects across hundreds of Fortune 500 companies, government agencies and NGOs. Visit


[email protected]

Example #4: Intent to acquire announcement

Example #5: Technology company to acquire customer relationship management company

Pulling Hair

Example #6: Acquisition closing announcement

Example #7: Major retailer announces acquisition of leading online seller of related products

Example #8: Company announces plan to spin off division and merge it with another company–intelligence-government-services-businesses-with-amentum-creating-an-independent-publicly-traded-company-301994253.html

Example #9: Companies agree to modify merger price

Example #10: Announcement of a definitive plan for acquisition

Example #11: Mutual agreement to cancel merger plans

Example #12: Acquisition termination and plan for updated proposal

Example #13: Withdrawl of non-binding plan to acquire

Example #14: Companies announce merger plans–doms-kitchen–market-announce-merger-301998529.html

Key Elements to Include in an Acquisition Press Release

  • Addressing the “5 Ws” in your press release

    Clarify who is involved, what the acquisition entails, when it was established, where it’s relevant, and why it matters. This foundational approach helps structure the press release and form a catchy headline.

  • Use a Standard Press Release Format

    Follow a concise format, similar to a news article, with a clear headline, subheading, and addressing the 5 Ws in the opening paragraph. The content should be structured in the inverted pyramid style, with the most crucial information at the top. Include quotes from senior leadership and conclude with additional details and a call-to-action if applicable.

  • Add Visuals and Hyperlinks

    To enhance engagement, include business logos or photos of personnel involved in the acquisition.

  • Writing Style Tips

    Keep the press release short and to the point, write in a journalistic style and in the third person, maintain a neutral tone, consider your target audience, and understand the media outlets you intend to pitch to.

Acquisition Press Release Template Examples

Work is always easier when you have a template into which you can insert your information. Since we’re all about making things easier for you, here are three press release templates to announce acquisitions:

Standard Acquisition Press Release Template


[Company Name] [Date]

[Headline: Your Company Name] Acquires [Acquired Company Name]

[Sub-header: Briefly state why this acquisition is significant.]

[City, Date]. [Your Company Name], [a brief description of your company], is excited to announce the acquisition of [Acquired Company Name], [a brief description of the acquired company]. This acquisition, which was officially announced [when and where the announcement was made], began [when and why the acquisition process started] and was completed on June 2024..

“[Insert quote from a high-level executive about the acquisition],” said [Name, Title].

The acquisition of [Acquired Company Name] aligns with [Your Company Name]’s strategy to [explain the purpose or strategy behind the acquisition]. Through this acquisition, [highlight the value and benefits expected from this move].

“[Insert another quote about the impact of the acquisition],” stated [Name, Title].

About [Your Company Name]

[Two to three sentences about what your company does, including major partners and mission statement].

Media Contact:

[Contact Name]

[Job Title]

[Email Address]

[Phone Number]

[Company Website]


Detailed Acquisition Press Release Template




[Headline: Your Company Name] Announces Strategic Acquisition of [Acquired Company Name]

[CITY, STATE] – [Your Company Name], a leader in [your industry/sector], is proud to announce the successful acquisition of [Acquired Company Name], a renowned [industry/sector] firm. This strategic move, effective as of June 2024., signifies a pivotal step in [Your Company Name]’s mission to [state your company’s strategic goals or vision].

The acquisition is set to [mention key benefits, synergies, or new opportunities]. It enables [Your Company Name] to [describe how the acquisition enhances your company’s capabilities or market reach].

“[Insert a quote expressing excitement about the acquisition],” said [Name], [Position] at [Your Company Name]. “Through this partnership, we aim to [describe potential achievements or goals post-acquisition].”

[Include an additional quote from another key figure or stakeholder regarding the acquisition].

[Your Company Name] is dedicated to a smooth integration process for [Acquired Company Name] and its workforce. Clients of [Acquired Company Name] will continue to receive the same level of exceptional service and support.

For further information, please visit [company website] or reach out to our media contact below.

About [Your Company Name]:

[Brief description of your company, its industry, and core values].

About [Acquired Company Name]:

[Brief description of the acquired company, its unique offerings, and strengths].

For Media Inquiries, Contact:

[Media Contact Name]


[Phone Number]


Simplified Acquisition Press Release Template



[Headline: Your Company Name] Successfully Acquires [Acquired Company Name]

[CITY, STATE] – [Your Company Name], a prominent player in [your industry/sector], is thrilled to announce the acquisition of [Acquired Company Name], a key player in [its industry/sector]. This acquisition, effective June 2024., marks a significant milestone in our journey towards [explain the strategic significance].

With this acquisition, [Your Company Name] is poised to [mention the main advantages or opportunities]. This move will enhance our ability to [explain how the acquisition benefits your company’s position or offerings].

“[Insert a thoughtful quote about the acquisition and its impact],” mentioned [Name], [Position] at [Your Company Name].

[Your Company Name] is committed to a smooth transition for the teams and customers of [Acquired Company Name]. We anticipate continued success and growth through this synergistic partnership.

Learn more about this exciting development at [company website].

About [Your Company Name]:

[Short description of your company and its mission].

About [Acquired Company Name]:

[Short description of the acquired company and its key strengths].

Media Contact:

[Contact Name]



[Phone Number]


Crafting Your Acquisition Press Release

Crafting an effective acquisition press release is a vital step in communicating significant business milestones.

The templates and examples provided here offer a blueprint for creating a compelling narrative around your company’s latest acquisition. They emphasize the importance of clarity, brevity, and strategic messaging while ensuring that all relevant details are conveyed in an engaging manner.

Whether you use the detailed, simplified, or standard template, each one is designed to cater to different needs and can be customized to reflect the unique aspects of your company and its recent acquisition.

By following these guidelines, you can create a press release that not only captures the essence of the acquisition but also garners the attention it deserves from media outlets, stakeholders, and the broader business community.

Ultimately, a well-crafted press release is more than just an announcement; it’s a powerful tool for shaping your company’s narrative and reinforcing its position in the market.

Press Release Examples Across Several Industries

And, just because I know you’ll appreciate them, here are another 15+ great press release examples for situations you may encounter.

Our Professionals write press releases for you

Additional Press Release Examples

Finally, here are some tips and training to help you write an amazing press release:

Additional Press Release Resources

Get real ROI on your press release, plus save 30% on your first order.